Macfarlane D E, Mills D C
Blood. 1975 Sep;46(3):309-20.
The influence of freshly purified ATP on the effects of aggregating agents on human platelets was studied. ATP inhibited aggregation induced by ADP competitively (Ki = 20 muM) and immediately without need for prior incubation. ATP had no effect on primary aggregation induced by adrenaline, thrombin, vasopressin, or 5-hydroxytryptamine (5HT). ATP inhibited the shape change and the consumption of metabolic ATP induced by ADP but did not inhibit these effects when induced by thrombin, vasopressin, or 5HT. ATP counteracted the inhibition by ADP of PGE1-stimulated cyclic AMP production in platelets but did not reduce inhibition by adrenaline. It is concluded that adrenaline, thrombin, 5HT, and vasopressin each can induce primary aggregation of human platelets by a mechanism independent of extracellular ADP.
研究了新鲜纯化的ATP对聚集剂作用于人类血小板的影响。ATP竞争性抑制ADP诱导的聚集(Ki = 20 μM),且无需预先孵育即可立即起效。ATP对肾上腺素、凝血酶、血管加压素或5-羟色胺(5HT)诱导的初级聚集无影响。ATP抑制ADP诱导的形态变化和代谢ATP的消耗,但不抑制凝血酶、血管加压素或5HT诱导的这些效应。ATP抵消了ADP对血小板中PGE1刺激的环磷酸腺苷生成的抑制作用,但不降低肾上腺素的抑制作用。得出的结论是,肾上腺素、凝血酶、5HT和血管加压素均可通过独立于细胞外ADP的机制诱导人类血小板的初级聚集。